Your browser doesn't support javascript.
loading
ImmunoPET Imaging with 89Zr-Labeled Atezolizumab Enables In Vivo Evaluation of PD-L1 in Tumorgraft Models of Renal Cell Carcinoma.
Mulgaonkar, Aditi; Elias, Roy; Woolford, Layton; Guan, Bing; Nham, Kien; Kapur, Payal; Christie, Alana; Tcheuyap, Vanina T; Singla, Nirmish; Bowman, I Alex; Stevens, Christina; Hao, Guiyang; Brugarolas, James; Sun, Xiankai.
Afiliación
  • Mulgaonkar A; Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Elias R; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Woolford L; Department of Internal Medicine, Hematology-Oncology, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Guan B; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Nham K; Department of Internal Medicine, Hematology-Oncology, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Kapur P; Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Christie A; Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Tcheuyap VT; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Singla N; Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Bowman IA; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Stevens C; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Hao G; Department of Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Brugarolas J; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Sun X; Department of Internal Medicine, Hematology-Oncology, University of Texas Southwestern Medical Center, Dallas, Texas.
Clin Cancer Res ; 28(22): 4907-4916, 2022 11 14.
Article en En | MEDLINE | ID: mdl-36074149
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos